Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

ClinicalTrials.gov ID: NCT00930553

Public ClinicalTrials.gov record NCT00930553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00930553
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
1,314 participants

Conditions and interventions

Interventions

  • alemtuzumab Biological

Biological

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2009
Primary completion
Jan 31, 2016
Completion
Jan 31, 2016
Last update posted
May 14, 2017

2009 – 2016

United States locations

U.S. sites
69
U.S. states
31
U.S. cities
63
Facility City State ZIP Site status
North Central Neurology Associates, P.C. Cullman Alabama
HOPE Research Institute Phoenix Arizona
St. Joseph's Hospital and Medical Center Barrow Neurology Clinics - Barrow Neurological Institute Phoenix Arizona
Mayo Clinic Arizona (Scottsdale) Scottsdale Arizona
Northwest NeuroSpecialists, PLLC Tucson Arizona
East Bay Physicians Medical Group/ Sutter East Bay Medical Foundation Berkeley California
Neurology Center North Orange County La Habra California
University of Southern California Keck School of Medicine/University of Southern California LAC & USC Medical Center Los Angeles California
Neuro-Therapeutics, Inc. Pasadena California
Stanford University Medical Center Stanford California
University of Colorado Health Science Center - Aurora Aurora Colorado
Advanced Neurology of Colorado Fort Collins Colorado
Yale MS Research Center New Haven Connecticut
The George Washington University Medical Faculty Associates Washington D.C. District of Columbia
University of Florida Neuroscience Institute Jacksonville Florida
Neurology Associates, P.A. Maitland Florida
Neurological Associates Pompano Beach Florida
Negroski, Stein, Sutherland and Hanes Neurology Sarasota Florida
Axiom Clinical Research of Florida Tampa Florida
University of South Florida College of Medicine Tampa Florida
Emory University Department of Neurology Atlanta Georgia
Shepherd Center Multiple Sclerosis Institute Atlanta Georgia
University of Chicago Medical Center Chicago Illinois
Consultants in Neurology, LTD Northbrook Illinois
Fort Wayne Neurological Center Fort Wayne Indiana
Indiana University Multiple Sclerosis Center Indianapolis Indiana
Iowa Health Physicians Des Moines Iowa
Ruan Neurology Clinic and Clinical Research Center, Mercy Medical Center Des Moines Iowa
University of Kansas Medical Center, Department of Neurology Kansas City Kansas
MidAmerica Neuroscience Institute Lenexa Kansas
Associates in Neurology, P.S.C. Lexington Kentucky
Kentucky Neuroscience Research Louisville Kentucky
University of Maryland, Maryland Center for MS Baltimore Maryland
The MS Center at St. Elizabeth's Boston Massachusetts
UMass Memorial Medical Center Worcester Massachusetts
University of Michigan Medical School Ann Arbor Michigan
Michigan Neurology Association Clinton Michigan
Wayne State University, The School of Medicine, Department of Neurology Detroit Michigan
Spectrum Health Medical Group, Neurology/Michigan Medical P.C., West Michigan MS Clinic Grand Rapids Michigan
Northern Michigan Neurology Traverse City Michigan
Saint Luke's Brain & Stroke Institute Kansas City Missouri
Renown Institute for Neurosciences Reno Nevada
Dartmouth Hitchcock Medical Center Lebanon New Hampshire
MS Center at Holy Name Hospital Teaneck New Jersey
University of New Mexico, Dept. of Neurology Albuquerque New Mexico
Empire Neurology P.C. Latham New York
Winthrop University Hospital Multiple Sclerosis Treatment Center Mineola New York
MS Care Center at NYUMC and HJD New York New York
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai New York New York
South Shore Neurologic Associates, P.C. Patchogue New York
Rochester Multiple Sclerosis Center Rochester New York
SUNY Upstate Medical University, Department of Neurology Syracuse New York
The University of North Carolina at Chapel Hill Chapel Hill North Carolina
Wake Forest University Health Science Department of Neurology Winston-Salem North Carolina
Cleveland Clinic Foundation Cleveland Ohio
Oak Clinic for Multiple Sclerosis Uniontown Ohio
OMRF Multiple Sclerosis Center of Excellence Oklahoma City Oklahoma
Lehigh Valley Hospital Neurosciences and Pain Research Allentown Pennsylvania
Rhode Island Hospital MS Center - The Neurology Foundation, Inc Providence Rhode Island
Neurology Clinic PC Cordova Tennessee
Advanced Neurosciences Institute Franklin Tennessee
Hope Neurology Knoxville Tennessee
Vanderbilt University Medical Center Nashville Tennessee
Baylor College of Medicine, Maxine Mesinger MS Clinic Houston Texas
Central Texas Neurology Consultants Round Rock Texas
Integra Clinical Research San Antonio Texas
Neurology Center of San Antonio San Antonio Texas
MS Center of Greater Washington Vienna Virginia
Swedish Medical MS Center Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 107 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00930553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2017 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00930553 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →